Clover Health Investments CorpNASDAQ:CLOVNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7020
- TODAY'S CHANGE (%)0.0070 (1.0072%)
- Bid / Lots0.7020/ 16
- Ask / Lots0.7021/ 70
- Open / Previous Close0.7120 / 0.6950
- Day Range
- 52 Week Range
- Volume691,325
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CLOV |
|---|---|---|
| 09:32 ET | 81155 | 0.712 |
| 09:34 ET | 14945 | 0.7087 |
| 09:36 ET | 33465 | 0.702 |
| 09:38 ET | 13915 | 0.7052 |
| 09:39 ET | 28929 | 0.7049 |
| 09:41 ET | 8546 | 0.706399 |
| 09:43 ET | 6989 | 0.708442 |
| 09:45 ET | 12473 | 0.71 |
| 09:48 ET | 31764 | 0.7165 |
| 09:50 ET | 25162 | 0.7158 |
| 09:52 ET | 29976 | 0.7138 |
| 09:54 ET | 27190 | 0.7114 |
| 09:56 ET | 41168 | 0.7101 |
| 09:57 ET | 98183 | 0.7137 |
| 09:59 ET | 25769 | 0.71 |
| 10:01 ET | 3792 | 0.710949 |
| 10:03 ET | 56227 | 0.705 |
| 10:06 ET | 22307 | 0.7053 |
| 10:08 ET | 49188 | 0.702 |
| 10:10 ET | 12182 | 0.702 |
May 1, 2024
Apr 30, 2024
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4), from 4:15PM ET on Tuesday Apr 30, 2024 by Dow Jones
4:15PM ET on Tuesday Apr 30, 2024 by Dow Jones
Apr 23, 2024
Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024, from 4:05PM ET on Tuesday Apr 23, 2024 by Dow Jones
4:05PM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 22, 2024
DJ Clover Health Names Peter Kuipers as New CFO, from 4:32PM ET on Monday Apr 22, 2024 by Dow Jones
4:32PM ET on Monday Apr 22, 2024 by Dow JonesClover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer, from 4:05PM ET on Monday Apr 22, 2024 by Dow Jones
4:05PM ET on Monday Apr 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Clover Health Investments Corp | 344.6M | -1.6x | --- |
Alignment Healthcare Inc | 1.3B | -7.9x | --- |
Interpace Biosciences Inc | 6.2M | 5.7x | --- |
Progyny Inc | 3.0B | 52.7x | --- |
Molina Healthcare Inc | 19.9B | 18.5x | +12.22% |
Humana Inc | 38.6B | 20.0x | +9.96% |
Company Information
Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. The Company operates under two segments: Insurance and Non-Insurance. Through its Insurance segment, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's Non-Insurance segment consists of operations in connection with its participation in the Direct Contracting program. The Company’s subsidiaries include Clover Health Labs, LLC, Medical Service Professionals of NJ LLC, Clover HMO of New Jersey Inc., Clover Health Holdings, Inc. and Clover Health Partners, LLC.
Contact Information
- Headquarters
- 3401 Mallory Lane, Suite 210, Suite 320FRANKLIN, TN, United States 37067
- Phone
- 201-432-2133
- Fax
- 302-655-5049
Executives
- Executive Chairperson, Co-Founder
- Vivek Garipalli
- Chief Executive Officer, Co-Founder
- Andrew Toy
- Interim Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer
- Terrence Ronan
- Chief Executive Officer of Home Care
- Brady Priest
- Chief Executive Officer of Medicare Advantage
- Jamie Reynoso
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $344.6M |
|---|---|
Revenue (TTM) | $2.0B |
Shares Outstanding | 495.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.89 |
EPS | $-0.44 |
Book Value | $0.59 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 0.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -10.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
